A detailed history of Louis Dreyfus Family Office LLC transactions in Celularity Inc stock. As of the latest transaction made, Louis Dreyfus Family Office LLC holds 720,040 shares of CELU stock, worth $1.99 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
720,040
Previous 720,040 -0.0%
Holding current value
$1.99 Million
Previous $2.45 Million 32.07%
% of portfolio
2.57%
Previous 3.29%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$4.64 - $7.46 $3.34 Million - $5.37 Million
720,040 New
720,040 $3.69 Million

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $393M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Louis Dreyfus Family Office LLC Portfolio

Follow Louis Dreyfus Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louis Dreyfus Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Louis Dreyfus Family Office LLC with notifications on news.